![]() |
市场调查报告书
商品编码
1980258
草本市场规模、份额、成长及全球产业分析:按类型和应用划分,区域洞察及2026-2034年预测Herbal Medicine Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受消费者对天然疗法的偏好增强以及传统医疗体系全球一体化的推动,全球中药市场持续保持强劲增长势头。 2025年,全球中药市场规模为2,512.4亿美元,预计2026年将成长至2,711.4亿美元,到2034年将达到5,159.2亿美元,预测期内(2026-2034年)的复合年增长率(CAGR)为8.37%。
到 2025 年,欧洲将以 44.29% 的市场份额引领全球市场,这反映出消费者对植物性补充剂的高度接受度以及对草药产品的监管支持。
市场概览
草药是指由植物的根、叶、树皮、种子和萃取物製成的植物来源产品。它们广泛应用于製药、营养保健品、机能性食品和个人护理领域。人们对预防性医疗保健意识的提高、慢性病盛行率的上升以及对洁净标示配方的需求,正在推动市场扩张。
在亚太地区,阿育吠陀、传统中医、中草药和尤那尼等传统医疗体系仍然是主要需求来源,而在北美和欧洲,营养保健品和增强免疫力的补充剂越来越受欢迎。
草本市场趋势
草本营养补充品消费量增加
全球对草药营养补充品的需求正在激增。世界卫生组织(世卫组织)的数据显示,已开发国家约有10%至50%的人口使用某种形式的草药。在中国、印度、日本、越南、南非和孟加拉等开发中国家,草药产品通常是一种价格低廉且易于取得的首选治疗方案。
消费者越来越依赖草药产品来增强免疫力、治疗咳嗽感冒、肠胃问题、关节疼痛和发炎性疾病。这种对植物来源保健品的持续偏好预计将创造强劲的长期成长机会。
市场动态
市场驱动因素
开发中国家的高需求
在许多中低收入国家,传统中医是医疗保健的基础。全球超过80%的人口以某种形式依赖传统医学。草药通常以干药、粉末、胶囊、茶剂或外用製剂的形式使用。某些发展中地区监管壁垒的缺失进一步推动了该产业的快速扩张。
市场限制因素
化妆品业的严格监管准则
对化妆品中草本成分的监管,尤其是在欧洲,是一项挑战。安全检验、可追溯性要求以及对某些植物化合物的限制,都增加了合规成本并延长了核准流程。欧盟限製或禁止使用超过1600种化妆品成分,其中包括某些植物来源的物质,这可能会限制某些细分市场的成长。
市场机会
对天然化妆品成分的需求日益增长
个人护理和美容行业拥有巨大的成长潜力。消费者越来越倾向选择植物来源护肤、护髮产品和洁净标示的化妆品。製造商正透过顺应永续发展和健康理念,以草本成分取代合成化学物质,开闢新的扩张途径。
透过使用
到2025年,药品和膳食补充剂领域将占据最大的市场份额。这主要得益于市场对膳食补充剂、草本蛋白粉、免疫增强剂和抗衰老产品的强劲需求。
受植物来源化妆品和草本护肤品需求不断增长的推动,个人护理和美容产品领域预计将以 9.16% 的复合年增长率实现最高增长,预计到 2026 年将占市场份额的 24.53%。
按形式
粉状产品占据市场主导地位,预计2025年市场规模将达到1,186亿美元,占总需求的47.2%。这主要得益于传统的消费习惯和产品易于配製。该细分市场预计将以8.44%的复合年增长率成长。
预计到 2026 年,液体和凝胶细分市场将占据 35.11% 的市场份额,并以 8.86% 的复合年增长率增长,这得益于快速吸收以及在糖浆和外用溶液中日益增长的使用。
透过分销管道
零售药局和药局是推动市场发展的主要力量,预计2025年市场规模将达到993亿美元,占全球销售额的39.5%。非处方药的普及和消费者的高度信任是该领域主导的关键因素。
同时,受数位医疗、宅配服务和跨境线上销售的普及推动,电子药局和线上平台正在经历最快的成长。
欧洲
预计2025年,欧洲市场规模将达到1,112.7亿美元,占全球市场的44.29%,年复合成长率为7.79%。德国将引领该地区,2026年市场规模将达211.6亿美元,其次是英国, 2026年市场规模将达160.2亿美元。
北美洲
预计到2025年,北美市场规模将达到352亿美元,占全球市场份额的13.99%,复合年增长率(CAGR)为8.18%,在所有地区中最高。预计到2026年,美国市场规模将达到239.1亿美元。
亚太地区
预计到2025年,亚太地区市场规模将达到844亿美元,占全球市场份额的33.6%,年复合成长率为9.36%。预计中国市场规模在2025年将达到195亿美元,在2026年将达到211.6亿美元,而印度市场规模在2026年将达到75.5亿美元。
南美洲、中东和非洲
预计到2025年,南美洲的市场规模将达到125亿美元,而中东和非洲的市场规模将达到79亿美元。预计这两个地区在预测期内都将保持稳定成长。
The global herbal medicine market continues to demonstrate strong growth momentum, driven by rising consumer preference for natural therapeutics and increasing global integration of traditional medicine systems. The global herbal medicine market size was valued at USD 251.24 billion in 2025 and is projected to grow to USD 271.14 billion in 2026, reaching USD 515.92 billion by 2034, registering a CAGR of 8.37% during the forecast period (2026-2034).
In 2025, Europe dominated the global market with a 44.29% share, reflecting strong consumer adoption of botanical supplements and regulatory support for herbal products.
Market Overview
Herbal medicines are plant-derived products formulated from roots, leaves, bark, seeds, and extracts. They are widely used across pharmaceuticals, nutraceuticals, functional foods, and personal care applications. Growing awareness of preventive healthcare, increasing chronic disease prevalence, and demand for clean-label formulations are supporting market expansion.
Traditional systems such as Ayurveda, Traditional Chinese Medicine (TCM), Kampo, and Unani remain central to demand in Asia Pacific, while North America and Europe are witnessing rising adoption through nutraceuticals and immunity-boosting supplements.
Herbal Medicine Market Trends
Heightened Consumption of Herbal Dietary Supplements
The demand for herbal dietary supplements has surged globally. According to the World Health Organization (WHO), approximately 10-50% of the population in developed countries uses herbal medicines in some form. In developing countries such as China, India, Japan, Vietnam, South Africa, and Bangladesh, herbal products often serve as affordable and accessible primary treatment options.
Consumers increasingly rely on herbal products for immunity enhancement, cough and cold treatment, gastrointestinal issues, joint pain, and inflammatory conditions. This sustained shift toward botanical supplements is expected to create strong long-term growth opportunities.
Market Dynamics
Market Drivers
High Demand from Developing Countries
In many low- and middle-income countries, herbal medicine forms the backbone of primary healthcare. Over 80% of the global population relies partly on traditional medicine. Herbs are commonly used in dried, powdered, capsule, tea, or topical forms. Minimal regulatory barriers in certain developing regions further support rapid industry expansion.
Market Restraints
Strict Regulatory Guidelines in Cosmetics
Regulatory scrutiny over herbal raw materials in cosmetics, particularly in Europe, poses challenges. Safety validation, traceability requirements, and restrictions on certain botanical compounds increase compliance costs and extend approval timelines. The European Union has restricted or prohibited more than 1,600 cosmetic ingredients, including certain plant-derived substances, which may limit growth in specific segments.
Market Opportunities
Rising Demand for Natural Cosmetic Ingredients
The personal care and beauty industry presents significant growth potential. Consumers increasingly demand botanical-based skincare, haircare, and clean-label cosmetics. Manufacturers are replacing synthetic chemicals with herbal alternatives to align with sustainability and wellness trends, unlocking new expansion avenues.
By Application
The pharmaceutical & nutraceutical segment held the largest market share in 2025, driven by strong demand for dietary supplements, herbal protein powders, immunity boosters, and anti-aging products.
The personal care & beauty products segment is projected to grow at the fastest CAGR of 9.16%, accounting for 24.53% market share in 2026, supported by rising demand for botanical cosmetics and herbal skincare formulations.
By Form
The powder segment dominated the market, valued at USD 118.6 billion in 2025, accounting for 47.2% of total demand, supported by traditional consumption practices and ease of formulation. The segment is projected to grow at a CAGR of 8.44%.
The liquid & gel segment accounted for 35.11% share in 2026 and is expected to grow at a CAGR of 8.86%, supported by faster absorption and increasing use in syrups and topical solutions.
By Distribution Channel
The retail pharmacies/drug stores segment led the market, valued at USD 99.3 billion in 2025, representing 39.5% of global sales. OTC availability and strong consumer trust drive segment dominance.
Meanwhile, e-pharmacies & online platforms are witnessing the fastest growth, fueled by digital health adoption, home delivery services, and cross-border online sales.
Europe
Europe accounted for USD 111.27 billion in 2025, representing 44.29% of the global market, and is projected to grow at a CAGR of 7.79%. Germany leads the region, valued at USD 21.16 billion in 2026, followed by the U.K. at USD 16.02 billion in 2026.
North America
North America was valued at USD 35.2 billion in 2025, accounting for 13.99% market share, and is projected to register the fastest regional CAGR of 8.18%. The U.S. accounted for USD 23.91 billion in 2026.
Asia Pacific
Asia Pacific was valued at USD 84.4 billion in 2025, representing 33.6% of global share, and is projected to grow at a CAGR of 9.36%. China was valued at USD 19.5 billion in 2025, reaching USD 21.16 billion in 2026, while India reached USD 7.55 billion in 2026.
South America & Middle East & Africa
South America was valued at USD 12.5 billion in 2025, while the Middle East & Africa accounted for USD 7.9 billion in 2025. Both regions are expected to witness steady growth during the forecast period.
Competitive Landscape
Key companies operating in the global herbal medicine market include:
Companies are focusing on product innovation, digital expansion, sustainable sourcing, and collaborations with regional distributors to strengthen market position.
Conclusion
The global herbal medicine market is set for sustained growth, expanding from USD 251.24 billion in 2025 to USD 271.14 billion in 2026, and projected to reach USD 515.92 billion by 2034, at a CAGR of 8.37%. Europe remains the leading region with a 44.29% share in 2025, while Asia Pacific is expected to witness the fastest expansion. Rising consumer inclination toward natural healthcare, increasing nutraceutical demand, expanding cosmetic applications, and growing regulatory recognition of traditional medicine systems are expected to drive long-term market growth globally.
Segmentation By Application
By Form
By Distribution Channel
By Region